MUMBAI, India, Sept. 14 -- Intellectual Property India has published a patent application (202617050665 A) filed by Repare Therapeutics, Inc. on April 21, 2026, for Combination Therapies Including Myt1 Inhibitors And Wee1 Inhibitors.
Inventors include Gallo, David; Zimmermann, Michal; Morris, Stephen; Fourtounis, Jimmy; and Marshall, Gary.
The application for the patent was published on September 11, 2026, under issue no. 37/2026.
Abstract: This application relates the use of a combination of a membrane-associated tyrosine and threonine- specific CDC2-inhibitory kinase (Myt1) inhibitor with a Weel inhibitors in treating cancer or inducing cell death. The synergistic effect of the combination results in a subtherapeutic dose or a reduced ...